issue

Nov 14, 2025

Volume 21 Number 22

The PCR London Valves issue of EuroIntervention opens with a state-of-the-art on TAVI in biscuspid aortic stenosis; followed by an expert consensus commissioned by the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC on transcatheter tricuspid valve interventions in patients with transvalvular right ventricular leads; a Viewpoint on the ACURATE platform discontinuation; original research on coronary cannulation after transfemoral TAVI with the Evolut FX; HALT after TAVI with the SAPIEN Ultra RESILIA; the impact of aortic annular size on long-term outcomes and valve durability; the TRICURE first-in-human study; 5-year follow-up of EVOQUE TTVR; and more...

Editorial

Transcatheter aortic valve alignment: substantial progress, remaining gaps
Amat-Santos I, Pensotti F
10.4244/EIJ-E-25-00041
free

State of the art

Transcatheter treatment of bicuspid aortic valve stenosis
Tchétché D, Willemen Y, Cesario V, Backer O
10.4244/EIJ-D-24-01069
free

Expert Consensus

Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society
Deharo J, Dreyfus J, Bongiorni M, Burri H, Defaye P, Glikson M, Lever N, Mangieri A, Mondésert B, Nielsen J, Shah M, Starck C, Rao A, Leclercq C, Praz F, Richter S, Amabile N, Breitenstein A, Cano Ó, Čurila K, Manlucu J, Schaller R, Tse H, Veltmann C, Whinnett Z
10.4244/EIJ-JAA-202501

Original Research

Incidence, predictors, and clinical impact of hypoattenuating leaflet thickening following SAPIEN 3 Ultra RESILIA implantation
Ishizu K, Shirai S, Hayashi M, Morofuji T, Isotani A, Ohno N, Kakumoto S, Ando K, Yamamoto M, Ochiai T, Tsunaki T, Hioki H, Shimura T, Yashima F, Asami M, Yamanaka F, Ohno Y, Nakazawa G, Hachinohe D, Fuku Y, Otsuka T, Hayashida K, of the OCEAN-TAVI investigators o
10.4244/EIJ-D-25-00523

Editorial comment

Long-term outcomes and durability of balloon-expandable TAVI in small and large annuli
Yamamoto M, Hioki H, Kagase A, Tsunamoto H, Tokuda T, Sugiura A, Shimura T, Murata A, Yamaguchi R, Shirai S, Ishizu K, Ohno Y, Yashima F, Naganuma T, Watanabe Y, Yamanaka F, Nakazawa G, Noguchi M, Izumo M, Asami M, Nishina H, Fuku Y, Otsuka T, Hayashida K, the OCEAN-TAVI investigators o
10.4244/EIJ-D-25-00682
Assessment of coronary cannulation after TAVI with the Evolut FX valve: the CANNULATE TAVR EXPANDED study
Ohno Y, Kamioka N, Miyamoto J, Omura R, Horinouchi H, Hashimoto K, Noda S, Murakami T, Ikari Y, Okada K, Frazzetto M, Raheja H, Lodi H, Rushing G, Ukaigwe A, Filby S, Yoon S, Feroze R, Palma Dallan L, Attizzani G, obotCTEi
10.4244/EIJ-D-24-01050
TRICURE: first-in-human study of the Topaz transcatheter tricuspid heart valve system
Teiger E, Nejjari M, Rosseel L, Kefer J, Verheye S, Lancellotti P, Oliver L, Obadia J, Asch F, Blanke P, Dreyfus J
10.4244/EIJ-D-25-00423

Flashlight

Five-year follow-up of transcatheter tricuspid valve replacement with the EVOQUE valve
Millar K, Husain A, Moss R, Boone R, Webb J
10.4244/EIJ-D-25-00195

Letter to the editor

Reply: Transcatheter aortic valve implantation and covert brain injury: does silence equal reassurance?
Jimenez Diaz V, Salvadores P, Lamas P, obotAi
10.4244/EIJ-D-25-00890
free

Receive our newsletter

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved